GCH1
GTP cyclohydrolase 1
Also known as: DYT14, DYT5, DYT5a, GCH, GCH1_HUMAN, GTPCH1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P30793
- Gene
- GCH1
- Ensembl
- ENSG00000131979
- Chromosome
- 14
- Canonical length
- 250 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear membrane,Cytosol
- Quaternary structure
- Homodecamer
OverviewNCBI Gene
This gene encodes a member of the GTP cyclohydrolase family. The encoded protein is the first and rate-limiting enzyme in tetrahydrobiopterin (BH4) biosynthesis, catalyzing the conversion of GTP into 7,8-dihydroneopterin triphosphate. BH4 is an essential cofactor required by aromatic amino acid hydroxylases as well as nitric oxide synthases. Mutations in this gene are associated with malignant hyperphenylalaninemia and dopa-responsive dystonia. Several alternatively spliced transcript variants encoding different isoforms have been described; however, not all variants give rise to a functional enzyme. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
250 residues, UniProt reviewed canonical sequence.
>P30793|GCH1
1 MEKGPVRAPA EKPRGARCSN GFPERDPPRP GPSRPAEKPP RPEAKSAQPA DGWKGERPRS
61 EEDNELNLPN LAAAYSSILS SLGENPQRQG LLKTPWRAAS AMQFFTKGYQ ETISDVLNDA
121 IFDEDHDEMV IVKDIDMFSM CEHHLVPFVG KVHIGYLPNK QVLGLSKLAR IVEIYSRRLQ
181 VQERLTKQIA VAITEALRPA GVGVVVEATH MCMVMRGVQK MNSKTVTSTM LGVFREDPKT
241 REEFLTLIRSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GCH1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 58 nTPM
Expression across tissuesHPA
Tissue
- liver: 58 nTPM
- bone marrow: 30 nTPM
- lung: 13 nTPM
- kidney: 10 nTPM
- duodenum: 8.8 nTPM
- spleen: 8.5 nTPM
Single-cell type
- neutrophils: 700 nCPM
- monocytes: 410 nCPM
- neuroendocrine cells: 318 nCPM
- pancreatic islet cells: 242 nCPM
- monocyte progenitors: 157 nCPM
- neutrophil progenitors: 157 nCPM
Immune cell
- non-classical monocyte: 11 nTPM
- intermediate monocyte: 5.3 nTPM
- gdT-cell: 2.9 nTPM
- myeloid DC: 2.8 nTPM
- classical monocyte: 2.6 nTPM
- naive CD4 T-cell: 2.5 nTPM
Brain region
- midbrain: 31 nTPM
- pons: 19 nTPM
- hypothalamus: 17 nTPM
- medulla oblongata: 7.6 nTPM
- basal ganglia: 6.5 nTPM
- spinal cord: 5.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GCH1.
Disease | AllUniProt
Conditions GCH1 is implicated in, by any mechanism.
- Hyperphenylalaninemia, BH4-deficient, B (HPABH4B) MIM:233910
- Dystonia, dopa-responsive (DRD) MIM:128230
Disease | GeneticClinVar
117 pathogenic / likely-pathogenic of 619 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Dystonia 5
- GTP cyclohydrolase I deficiency
- GTP cyclohydrolase I deficiency with hyperphenylalaninemia
- Dystonic disorder
- Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.4
- gnomAD pLI
- 0.9
- gnomAD missense Z
- 1.52
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- dopamine biosynthetic process
- neuromuscular process controlling posture
- nitric oxide biosynthetic process
- positive regulation of heart rate
- positive regulation of nitric-oxide synthase activity
- regulation of blood pressure
- regulation of lung blood pressure
- regulation of removal of superoxide radicals
- response to lipopolysaccharide
- response to pain
- response to tumor necrosis factor
- response to type II interferon
- tetrahydrobiopterin biosynthetic process
- tetrahydrofolate biosynthetic process
- pteridine-containing compound biosynthetic process
Molecular functions
- GTP binding
- GTPase activity
- identical protein binding
- mitogen-activated protein kinase binding
- protein homodimerization activity
- zinc ion binding
- GTP cyclohydrolase I activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GTP cyclohydrolase I
- GTP cyclohydrolase I, conserved site
- GTP cyclohydrolase I domain
- GTP cyclohydrolase I, C-terminal/NADPH-dependent 7-cyano-7-deazaguanine reductase
- GTP cyclohydrolase I, N-terminal domain
- GTP cyclohydrolase I
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GCH1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GCH1 as an antibody target. Whether an autoantibody or antibody against GCH1 could matter depends on whether native GCH1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GCH1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GCH1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...